Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59,287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reducing adverse impacts of Amazon hydropower expansion.
Flecker AS, Shi Q, Almeida RM, Angarita H, Gomes-Selman JM, García-Villacorta R, Sethi SA, Thomas SA, Poff NL, Forsberg BR, Heilpern SA, Hamilton SK, Abad JD, Anderson EP, Barros N, Bernal IC, Bernstein R, Cañas CM, Dangles O, Encalada AC, Fleischmann AS, Goulding M, Higgins J, Jézéquel C, Larson EI, McIntyre PB, Melack JM, Montoya M, Oberdorff T, Paiva R, Perez G, Rappazzo BH, Steinschneider S, Torres S, Varese M, Walter MT, Wu X, Xue Y, Zapata-Ríos XE, Gomes CP. Flecker AS, et al. Among authors: wu x. Science. 2022 Feb 18;375(6582):753-760. doi: 10.1126/science.abj4017. Epub 2022 Feb 17. Science. 2022. PMID: 35175810
Reducing greenhouse gas emissions of Amazon hydropower with strategic dam planning.
Almeida RM, Shi Q, Gomes-Selman JM, Wu X, Xue Y, Angarita H, Barros N, Forsberg BR, García-Villacorta R, Hamilton SK, Melack JM, Montoya M, Perez G, Sethi SA, Gomes CP, Flecker AS. Almeida RM, et al. Among authors: wu x. Nat Commun. 2019 Sep 19;10(1):4281. doi: 10.1038/s41467-019-12179-5. Nat Commun. 2019. PMID: 31537792 Free PMC article.
Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial.
Xu B, Zhang Q, Luo Y, Tong Z, Sun T, Shan C, Liu X, Yao Y, Zhao B, Wang S, Zeng X, Hu C, Yan X, Wang X, Jia H, Chen Z, Qiu F, Wu X, Zhang D, Li T. Xu B, et al. Among authors: wu x. Nat Commun. 2025 Jan 16;16(1):716. doi: 10.1038/s41467-025-56096-2. Nat Commun. 2025. PMID: 39820749 Clinical Trial.
59,287 results
You have reached the last available page of results. Please see the User Guide for more information.